Invention Grant
- Patent Title: Tricyclic compound
- Patent Title (中): 三环化合物
-
Application No.: US14381347Application Date: 2013-03-06
-
Publication No.: US09556200B2Publication Date: 2017-01-31
- Inventor: Tomokazu Kusumoto , Shigekazu Sasaki , Hironobu Maezaki
- Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Applicant Address: JP Osaka
- Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Current Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Current Assignee Address: JP Osaka
- Agency: Wenderoth, Lind & Ponack, L.L.P.
- Priority: JP2012-049431 20120306
- International Application: PCT/JP2013/056154 WO 20130306
- International Announcement: WO2013/133325 WO 20130912
- Main IPC: A61K31/55
- IPC: A61K31/55 ; C07D487/06 ; C07D495/06 ; C07D491/06

Abstract:
The present invention provides a compound having a superior serotonin 5-HT2C receptor activating action.The present invention relates to a compound represented by the formula (1) wherein ring A is an aromatic carbocycle optionally having substituent(s) or an aromatic heterocycle optionally having substituent(s), X is —N(R1)—, —O— or the like, when ring A is an aromatic carbocycle optionally having substituent(s), then R1 is a hydrogen atom, an alkyl group optionally having substituent(s), or the like, and when ring A is an aromatic heterocycle optionally having substituent(s), then R1 is a hydrogen atom, an alkyl group optionally having substituent(s), a cycloalkyl group optionally having substituent(s), or the like, is a single bond or a double bond, and n is an integer of 0, 1 or 2, or a salt thereof.
Public/Granted literature
- US20150045351A1 TRICYCLIC COMPOUND Public/Granted day:2015-02-12
Information query